基本信息:
- 专利标题： 含有多不饱和脂肪酸、蛋白质及锰和/或钼的组合物
- 专利标题（英）：Compositions comprising polyunsaturated fatty acids, proteins and manganese and / or molybdenum
- 申请号：CN201710513954.6 申请日：2006-12-22
- 公开(公告)号：CN107495379A 公开(公告)日：2017-12-22
- 发明人： 罗伯特·约翰·约瑟夫·哈格曼 , 马托伊斯·科内利斯·德维尔德 , 帕特里克·约瑟夫·赫拉尔杜斯·亨德里克 , 斯·坎普乌斯
- 申请人： N.V.努特里西阿公司
- 申请人地址： 荷兰苏特尔梅尔
- 专利权人： N.V.努特里西阿公司
- 当前专利权人： N.V.努特里西阿公司
- 当前专利权人地址： 荷兰苏特尔梅尔
- 代理机构： 北京康信知识产权代理有限责任公司
- 代理人： 沈敬亭; 徐丽华
- 优先权： 05077972.7 2005.12.23 EP
- 主分类号： A23L33/115
- IPC分类号： A23L33/115 ; A23L33/175 ; A23L33/16 ; A61K45/06 ; A61K31/202 ; A61K33/24 ; A61K33/32 ; A61K31/198 ; A61K31/185 ; A61K31/7072 ; A61K31/14 ; A61K36/064 ; A61K31/355 ; A61K31/375 ; A61K33/04 ; A61K33/06 ; A61K33/30 ; A61P25/28 ; A61P37/08 ; A61P37/02 ; A61P3/04 ; A61P29/00 ; A61P3/10 ; A61P9/06 ; A61P9/04 ; A61P35/00 ; A61P11/00 ; A61P19/02 ; A61P1/16 ; A61P1/18
It has now been found that after administration to a diseased person or person that is at risk for developing such disease of a neutraceutical or pharmaceutical composition that comprises a lipid fraction comprising at least one of docosahexaneoic acid (DHA), docosapentaenoic acid (DPA) and eicosapentaenoic acid (EPA); an uracil source; a protein fraction comprising proteinaceous material from non-human origin which provide at least cysteine and/or taurine; and a mineral fraction comprising at least one of manganese and molybdene, the health of these persons improves. Membrane function of several types of mammalian cells improves, which allows efficient treatment of immune related disorders, such as allergy, autoimmune diseases, cancer, cognitive dysfunction and other diseases of the nervous system, neuropathies, such as diabetic neuropathies and neuropathic pains, neuronal damage during insulin resistance, and gut diseases and support of the development of gut and lung function during growth or recovery.